ZA200104596B - IBDV strain for in ovo administration. - Google Patents

IBDV strain for in ovo administration.

Info

Publication number
ZA200104596B
ZA200104596B ZA200104596A ZA200104596A ZA200104596B ZA 200104596 B ZA200104596 B ZA 200104596B ZA 200104596 A ZA200104596 A ZA 200104596A ZA 200104596 A ZA200104596 A ZA 200104596A ZA 200104596 B ZA200104596 B ZA 200104596B
Authority
ZA
South Africa
Prior art keywords
ovo administration
ibdv strain
ibdv
strain
ovo
Prior art date
Application number
ZA200104596A
Other languages
English (en)
Inventor
Egberg Mundt
Adriaan Wilhelmus Maria V Loon
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA200104596B publication Critical patent/ZA200104596B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200104596A 2000-06-09 2001-06-05 IBDV strain for in ovo administration. ZA200104596B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202042 2000-06-09

Publications (1)

Publication Number Publication Date
ZA200104596B true ZA200104596B (en) 2001-12-06

Family

ID=8171620

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200104596A ZA200104596B (en) 2000-06-09 2001-06-05 IBDV strain for in ovo administration.

Country Status (9)

Country Link
US (2) US6451321B1 (hu)
JP (1) JP2002045175A (hu)
KR (1) KR20020013378A (hu)
AU (1) AU782013B2 (hu)
BR (1) BR0102322A (hu)
CA (1) CA2349960A1 (hu)
HU (1) HUP0102389A3 (hu)
MX (1) MXPA01005808A (hu)
ZA (1) ZA200104596B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
JP2002153262A (ja) * 2000-11-20 2002-05-28 Shibuya Kogyo Co Ltd 鶏卵の処理方法および処理装置
AU2002235158A1 (en) * 2000-12-01 2002-06-11 Vigilos, Inc. System and method for processing video data utilizing motion detection and subdivided video fields
US20050214316A1 (en) 2003-11-13 2005-09-29 Brown Thomas P Methods of characterizing infectious bursal disease virus
WO2005100554A1 (ja) * 2004-03-31 2005-10-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 新規な伝染性ファブリキウス嚢病ウイルス、及び当該ウイルスを含有するワクチン
US7491399B2 (en) * 2005-06-23 2009-02-17 University Of Maryland Biotechnology Institute In Ovo vaccine against infectious bursal disease
US20100003279A1 (en) * 2005-12-22 2010-01-07 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Vaccine for in ovo inoculation
KR20120042865A (ko) * 2006-03-30 2012-05-03 엠브렉스, 인코포레이티드 가금류의 예방접종 방법 및 조성물
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192539A (en) 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
DE69030383T2 (de) * 1989-10-02 1997-10-23 Univ Arkansas Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten
EP0861665A1 (en) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Infectious bursitis vaccine
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
EP1161953A3 (en) * 2000-06-09 2004-02-04 Akzo Nobel N.V. IBDV strain for in OVO administration

Also Published As

Publication number Publication date
CA2349960A1 (en) 2001-12-09
HUP0102389A2 (hu) 2002-04-29
US6451321B1 (en) 2002-09-17
BR0102322A (pt) 2002-02-13
AU782013B2 (en) 2005-06-30
HUP0102389A3 (en) 2005-06-28
HU0102389D0 (en) 2001-08-28
MXPA01005808A (es) 2004-11-10
AU5179101A (en) 2002-01-03
US20030068334A1 (en) 2003-04-10
KR20020013378A (ko) 2002-02-20
JP2002045175A (ja) 2002-02-12

Similar Documents

Publication Publication Date Title
MXPA02005950A (es) Silla.
EG24742A (en) Vaccine composition.
HK1034478A1 (en) Game system.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
MXPA03002410A (es) 4-amino-quinazolinas.
ZA200200743B (en) Preserved pharmaceutical formulations.
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200101012B (en) Pharmaceutical combinations.
HK1049798A1 (en) Solid lipid formulations.
HK1046476A1 (en) Jack.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
MXPA02008907A (es) Capsulas.
EG23262A (en) Delta -pyrrolines.
MXPA01012478A (es) Formulaciones farmaceuticas mejoradas.
ZA200203707B (en) Pharmaceutical combinations.
HK1056872A1 (en) Indoloquinazolinones.
MXPA03001591A (es) Derivados y analogos de 10-aril-11-h-benzo(b) fluorena para uso medicinal.
HK1038324A1 (en) Game system.
MXPA03001877A (es) 2-guanidin-4-arilquinazolinas.
ZA200104596B (en) IBDV strain for in ovo administration.
MXPA03002411A (es) 4-amino-quinazolinas.
HK1061560A1 (en) Triazolo-epothilones.
GB2360279B (en) I.S. Machine
GB0029720D0 (en) I.S machine7544232001